Literature DB >> 11793437

Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma.

Nallasivam Palanisamy1, Ashraf A Abou-Elella, Seeta R Chaganti, Jane Houldsworth, Kenneth Offit, Diane C Louie, Julie Terayu-Feldstein, Juan C Cigudosa, Pulivarthi H Rao, Warren G Sanger, Dennis D Weisenburger, R S K Chaganti.   

Abstract

To address the possible genetic relationship between primary mediastinal large-B-cell lymphoma (PMLBCL) and diffuse large-B-cell lymphoma (DLBCL), we compared DNA copy number changes identified by comparative genomic hybridization (CGH) analysis of 40 PMLBCL and 91 DLBCL tumors. We assessed their karyotypes by G-banding; amplification of MYC, BCL2, and REL genes by Southern blotting; and incidence of nonpolymorphic BCL6 mutations by single-strand conformation polymorphism analysis (SSCP). Overall, CGH identified overlapping and nonoverlapping patterns of DNA copy number changes in the two groups. Among the latter changes, gains of chromosomes 8, 11, 15, and 16 and losses of chromosomes 5, 10, 15, 16, 17, and 20 were seen only in DLBCL, and gains of chromosomes 10, 21, and 22 and losses of chromosomes 11, 13, and 18 were seen only in PMLBCL. Several overlapping changes were identified in both groups, with variation in incidence. Statistical analysis of these changes showed significant gains of chromosomes 3 (P <or= 0.05) and 7q (P <or= 0.05) in DLBCL and gains of chromosomes 9 (P <or= 0.05) and 19 (P <or= 0.05) and the X chromosome (P <or= 0.05) and loss of chromosome 4 (P <or= 0.05) in PMLBCL. Frequent recurring DNA amplification at 2p13-15 and less frequent amplification at 6p21, 12q13, and 18q21 were noted in both groups. Recurring amplification at 1q21 was seen only in DLBCL, whereas nonrecurring amplification at 10p11.2 and 15q22-24 was seen only in PMLBCL. G-banded karyotype analysis identified t(3;14)(q27;q32) in one and t(14;18)(q32;q21) in two cases of PMLBCL. Seven of 13 cases exhibited SSCP variants in the 5' noncoding region of BCL6. In addition, 19 of 24 PMLBCLs assayed for BCL6 protein expression by immunohistochemistry showed positive results, indicating an origin from a germinal center (GC)-derived B cell. Based on these data, we conclude that PMLBCL is a distinct entity among GC-derived high-grade DLBCLs. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11793437     DOI: 10.1002/gcc.10016

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

1.  Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas.

Authors:  Weiyi Chen; Jane Houldsworth; Adam B Olshen; Gouri Nanjangud; Seeta Chaganti; Ennapadem S Venkatraman; Jeffrey Halaas; Julie Teruya-Feldstein; Andrew D Zelenetz; R S K Chaganti
Journal:  Blood       Date:  2005-11-29       Impact factor: 22.113

2.  Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.

Authors:  Silvia Bea; Andreas Zettl; George Wright; Itziar Salaverria; Philipp Jehn; Victor Moreno; Christof Burek; German Ott; Xavier Puig; Liming Yang; Armando Lopez-Guillermo; Wing C Chan; Timothy C Greiner; Dennis D Weisenburger; James O Armitage; Randy D Gascoyne; Joseph M Connors; Thomas M Grogan; Rita Braziel; Richard I Fisher; Erlend B Smeland; Stein Kvaloy; Harald Holte; Jan Delabie; Richard Simon; John Powell; Wyndham H Wilson; Elaine S Jaffe; Emili Montserrat; Hans-Konrad Muller-Hermelink; Louis M Staudt; Elias Campo; Andreas Rosenwald
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

3.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

4.  Primary mediastinal B-cell lymphoma: detection of BCL2 gene rearrangements by PCR analysis and FISH.

Authors:  Cherie H Dunphy; Dennis P O'Malley; Liang Cheng; Tina Y Fodrie; Sherrie L Perkins; Kathleen Kaiser-Rogers
Journal:  J Hematop       Date:  2008-06-18       Impact factor: 0.196

5.  Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer.

Authors:  Thomas Knösel; Karsten Schlüns; Ulrike Stein; Holger Schwabe; Peter Michael Schlag; Manfred Dietel; Iver Petersen
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

6.  Chromosomal alterations in lung metastases of colorectal carcinomas: associations with tissue specific tumor dissemination.

Authors:  Thomas Knösel; Karsten Schlüns; Manfred Dietel; Iver Petersen
Journal:  Clin Exp Metastasis       Date:  2006-02-11       Impact factor: 5.150

7.  Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

Authors:  Stefano A Pileri; Gianluca Gaidano; Pier Luigi Zinzani; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Federica Pieri; Eva Berra; Elena Sabattini; Stefano Ascani; Milena Piccioli; Peter W M Johnson; Roberto Giardini; Edoardo Pescarmona; Domenico Novero; Pier Paolo Piccaluga; Teresa Marafioti; Miguel A Alonso; Franco Cavalli
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

8.  STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).

Authors:  Olga Ritz; Karolin Rommel; Karola Dorsch; Elena Kelsch; Julia Melzner; Michaela Buck; Karen Leroy; Vasiliki Papadopoulou; Simon Wagner; Ralf Marienfeld; Silke Brüderlein; Jochen K Lennerz; Peter Möller
Journal:  Oncotarget       Date:  2013-07

Review 9.  Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature.

Authors:  Carlos A Tirado; Weina Chen; Rolando García; Kelly A Kohlman; Nagesh Rao
Journal:  J Hematol Oncol       Date:  2012-09-11       Impact factor: 17.388

10.  Hodgkin's lymphoma and infection: findings from a UK case-control study.

Authors:  R Newton; S Crouch; P Ansell; J Simpson; E V Willett; A Smith; C Burton; A Jack; E Roman
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.